-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Background: Lupus nephritis (LN) is an inflammation of the kidneys caused by the autoimmune disease systemic lupus erythematosus (SLE)
Lupus nephritis (LN) is an inflammation of the kidneys caused by the autoimmune disease systemic lupus erythematosus (SLE)
Objective: The combined treatment of mycophenolate mofetil, tacrolimus and steroid in lupus nephritis (LN) is effective
Methods: The expression and activation of GSDMD in human and mouse LN kidney tissues were detected by immunohistochemical staining and immunoblotting
RESULTS: The expression level and degree of lysis of GSDMD were significantly increased in renal tissue specimens from LN patients and mice
Conclusions: Combination therapy inhibits caspase-1/GSDMD-mediated pyroptosis and delays disease progression in vitro and in vivo
Combination therapy inhibits caspase-1/GSDMD-mediated pyroptosis and delays disease progression in vitro and in vivo
leave a message here